PAM
COGT icon

Panagora Asset Management’s Cogent Biosciences COGT Stock Holding History

Panagora Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-44,042
Closed -$632K – 1189
2025
Q3 		$632K Buy
+44,042
New +$522K ﹤0.01% 749
2025
Q1 		– Sell
-14,712
Closed -$115K – 1124
2024
Q4 		$115K Sell
14,712
-18
-0.1% -$179 ﹤0.01% 1109
2024
Q3 		$159K Sell
14,730
-231,603
-94% -$2.25M ﹤0.01% 1164
2024
Q2 		$2.08M Sell
246,333
-60,912
-20% -$462K 0.01% 511
2024
Q1 		$2.06M Buy
+307,245
New +$1.9M 0.01% 566
2021
Q2 		– Sell
-5
Closed – – 2807
2021
Q1 		$0 Buy
+5
New +$48 ﹤0.01% 2834
2020
Q3 		– Sell
-221
Closed – – 2708
2020
Q2 		$0 Hold
221
– – ﹤0.01% 2576
2020
Q1 		$0 Hold
221
– – ﹤0.01% 2523
2019
Q4 		$1K Buy
221
+75
+51% +$306 ﹤0.01% 2395
2019
Q3 		$1K Buy
+146
New +$1.19K ﹤0.01% 2406

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Panagora Asset Management's COGT Position: Q4 2025 in Review

Panagora Asset Management sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 44,042 shares — an estimated $632K sold.

Panagora Asset Management first reported a position in COGT in Q3 2019 and held it in 10 quarters. The position peaked at $2.08M in Q2 2024. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Panagora Asset Management reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 44,042 Cogent Biosciences shares in Q4 2025, an estimated $632K.
  • Panagora Asset Management first reported a position in Cogent Biosciences in Q3 2019 and held it in 10 quarters.
  • Panagora Asset Management's Cogent Biosciences position peaked at $2.08M in Q2 2024.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.